Enovis CORP Schedule 13G passive stakes

Rubric Capital Management LP and David Rosen have jointly filed a Schedule 13G, reporting beneficial ownership of 3,900,000 shares, representing 6.78% of Enovis Corporation's common stock.

American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have jointly filed a Schedule 13G, reporting beneficial ownership of Enovis Corporation common stock.

Vanguard Capital Management has filed a Schedule 13G reporting a 5.23% beneficial ownership stake in Enovis Corp.

Vanguard Portfolio Management has reported a beneficial ownership of 6.82% in Enovis Corp's common stock as of March 31, 2026.

The Vanguard Group has filed an amendment to its Schedule 13G for Enovis Corp, reporting zero beneficial ownership following an internal realignment.

Dimensional Fund Advisors LP filed an Amendment No. 2 to its Schedule 13G, reporting a 4.9% beneficial ownership in Enovis Corp's common stock as of December 31, 2025.

American Century Capital Portfolios, Inc. and its affiliates have filed an amended Schedule 13G, disclosing their beneficial ownership in Enovis Corporation's common stock.

Davenport & Co LLC has reported a 4.83% beneficial ownership stake in Enovis Corp's common stock as an investment adviser.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 14.9% of Enovis Corporation's common stock as of June 30, 2025.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a 0.0% beneficial ownership stake in Enovis Corp, indicating a passive investment.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, disclosing a 10.9% beneficial ownership stake in Enovis Corp's common stock as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, disclosing its continued beneficial ownership of 12.2% of Enovis CORP's common stock as of March 31, 2025.

American Century Investment Management, Inc., along with its affiliates, has disclosed a passive beneficial ownership of 6.4% of Enovis Corporation's common stock as of December 31, 2024.

The Vanguard Group has filed an Amendment No. 8 to its Schedule 13G, reporting a 10.7% passive beneficial ownership stake in Enovis Corp's common stock as of January 31, 2025.

Diamond Hill Capital Management Inc. has reported a 5.0% beneficial ownership stake in Enovis Corp.'s common stock as of December 31, 2024, held in the ordinary course of business.

Investment adviser Davenport & Co LLC has filed a Schedule 13G, reporting beneficial ownership of 5.8% of Enovis Corp's common stock as of January 31, 2025.